Emerging Trends In Cell & Gene Therapies For Immuno-Oncology

Emerging Trends In Cell & Gene Therapies For Immuno-Oncology

In January 2024, the rare disease therapeutics sector experienced a funding surge to nearly $3 billion, indicating a strong start to the year.

All of this by stage, disease indication, modality, target…

+ 0 k
Licensing Deals
+ 0 k
M&A
+ 0 k
Other Deals
+ 0 k
Funding Rounds
+ 0 k
Company Profiles
+ 0 k
Drug Sales Figures